精选理由
中国手术机器人公司TIANZHIHANG要收购美国骨科公司MicroPort Orthopedics，用钱换时间，跳过海外认证和市场积累，直接拿到技术和渠道。
TIANZHIHANG计划通过收购MicroPort Orthopedics，将海外监管审批、临床信任和分销网络建设压缩为单笔交易。此举使中国手术机器人企业从产品出口转向产业链反向整合，直接获取骨科植入物技术和海外市场渠道。若交易完成，TIANZHIHANG有望在手术机器人和骨科植入物领域实现协同效应，加速全球化布局。
原文 · pandaily
Chinese Robots Begin Restructuring the Global Supply Chain as TIANZHIHANG Attempts Reverse Integration From Surgical Robots to Orthopedic Implants and Overseas Markets
TIANZHIHANG plans to acquire MicroPort Orthopedics, compressing years of overseas regulatory, clinical trust, and distribution network building into a single transaction as Chinese robotics companies move beyond product-level export.